These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1949954)

  • 21. Impact of ceftriaxone de-restriction on the occurrence of ESBL-positive bacterial strains and antibiotic consumption.
    Skrlin J; Bacic Vrca V; Marusic S; Ciric-Crncec M; Mayer L
    J Chemother; 2011 Dec; 23(6):341-4. PubMed ID: 22233817
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A clinical trial of ceftriaxone in different bacterial infections.
    Kavakas H; Ellinas C; Matzakos K; Politikou L; Sahin A
    J Chemother; 1989 Jul; 1(4 Suppl):658-9. PubMed ID: 16312579
    [No Abstract]   [Full Text] [Related]  

  • 23. [Re-evaluation of current antimicrobials. Series 19: ceftriaxone. Discussion].
    Jpn J Antibiot; 1994 Nov; 47(11):1433-40. PubMed ID: 7853673
    [No Abstract]   [Full Text] [Related]  

  • 24. Ceftriaxone compared with cefotaxime for serious bacterial infections.
    Smith CR; Petty BG; Hendrix CW; Kernan WN; Garver PL; Fox K; Beamer A; Carbone K; Threlkeld M; Lietman PS
    J Infect Dis; 1989 Sep; 160(3):442-7. PubMed ID: 2668428
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ceftriaxone versus cefuroxime for treatment of bacterial meningitis.
    Weiss D; Glaser JH
    J Pediatr; 1990 Mar; 116(3):488-90, 492. PubMed ID: 2308045
    [No Abstract]   [Full Text] [Related]  

  • 26. A comparative study with ceftriaxone (Rocephin) versus ampicillin and chloramphenicol in children with bacterial meningitis.
    Ngu J; Youmbissi T
    Chemioterapia; 1987 Jun; 6(2 Suppl):417-8. PubMed ID: 3334588
    [No Abstract]   [Full Text] [Related]  

  • 27. Ceftriaxone in the treatment of bacterial meningitis in children.
    Prado V; Cohen J; Banfi A; Cordero J; Ledermann W; Cofré J; Reyes L
    Chemotherapy; 1986; 32(4):383-90. PubMed ID: 3731923
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of ceftriaxone use in the medical ward of Halibet National Referral and teaching hospital in 2017 in Asmara, Eritrea: a cross sectional retrospective study.
    Berhe YH; Amaha ND; Ghebrenegus AS
    BMC Infect Dis; 2019 May; 19(1):465. PubMed ID: 31126242
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Ceftriaxone in the ambulatory treatment of bacterial infections].
    Santa Cruz Valverde PL; Cruz Abascal R
    Med Clin (Barc); 1993 May; 100(18):718. PubMed ID: 8492604
    [No Abstract]   [Full Text] [Related]  

  • 30. [Ceftriaxone in the treatment of bacterial meningitis].
    Duniewicz M; Stanková M; Absolonová V; Lochmann O; Potuzník V; Brezinová J; Havlík J
    Cas Lek Cesk; 1986 Aug; 125(35):1093-6. PubMed ID: 3757000
    [No Abstract]   [Full Text] [Related]  

  • 31. The efficacy of ceftriaxone in the treatment of severe infections in hospitalized patients.
    Alexopoulos E; Anassis P; Hadjidimitrou C; Papadimitriou M
    Chemioterapia; 1987 Jun; 6(2 Suppl):380-1. PubMed ID: 3509452
    [No Abstract]   [Full Text] [Related]  

  • 32. Monotherapy with long half-life cephalosporins: example of ceftriaxone.
    Osborne JC
    Iowa Med; 1985 Oct; 75(10):460-6. PubMed ID: 4055303
    [No Abstract]   [Full Text] [Related]  

  • 33. [Ceftriaxone and severe infections in medical resuscitation].
    Gardère JJ; de Barbeyrac B; Penouil F; Louis C; Brachet-Liermain A; Favarel-Garrigues JC
    Pathol Biol (Paris); 1987 May; 35(5):608-12. PubMed ID: 3302867
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ceftriaxone versus cefuroxime for meningitis in children.
    Wrenn K
    N Engl J Med; 1990 Jun; 322(25):1821. PubMed ID: 2345571
    [No Abstract]   [Full Text] [Related]  

  • 35. [Ceftriaxone: world-wide experience with its clinical use].
    Hell K; Mendham NA; Haddad WG
    Antibiot Khimioter; 1992 Jul; 37(7):34-7. PubMed ID: 1456807
    [No Abstract]   [Full Text] [Related]  

  • 36. Ceftriaxone in the management of infected burns.
    Theron EJ; Nel CJ
    S Afr Med J; 1987 Jun; Suppl 2():18-9. PubMed ID: 3603256
    [No Abstract]   [Full Text] [Related]  

  • 37. Ceftriaxone in the treatment of meningitis, gonococcal infections and other serious bacterial infections. Infectious Diseases and Immunization Committee, Canadian Paediatric Society.
    CMAJ; 1990 Mar; 142(5):450-2. PubMed ID: 2302641
    [No Abstract]   [Full Text] [Related]  

  • 38. Use of ceftriaxone in the treatment of bacterial infections in cirrhotic patients.
    Mercader J; Gomez J; Ruiz J; Garre MC; Valdes M
    Chemotherapy; 1989; 35 Suppl 2():23-6. PubMed ID: 2612236
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comment: cefazolin versus ceftriaxone in lower respiratory tract infection.
    Wood WA
    Ann Pharmacother; 1993 May; 27(5):653-4. PubMed ID: 8347923
    [No Abstract]   [Full Text] [Related]  

  • 40. Cost-effective use of once-daily ceftriaxone: overview of a symposium.
    Periti P
    Chemotherapy; 1991; 37 Suppl 3():26-7. PubMed ID: 1909230
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.